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INTRODUCTION
Human embryonic stem cells (hESCs) are an invaluable model system to address mechanisms of early human development due to the ability to self-renew and differentiate into the majority of cell types in the mammalian embryo. Recent studies profiling RNA regulatory networks controlled by RNA binding proteins (RBPs), including RBFOX2, LIN28A, and MBNL, have demonstrated that RBPs play key roles in maintenance of pluripotency through regulating diverse aspects of RNA processing (Han et al., 2013; Wilbert et al., 2012; Yeo et al., 2009) .
The IGF2 mRNA binding proteins (IMPs/IGF2BPs) are a highly homologous family of RBPs that are conserved from insects to mammals (Hansen et al., 2004; Nielsen et al., 1999) . Humans and mice have three IMPs (IMP1-3/IGF2BP1-3), which are expressed broadly during early development. Protein expression generally decreases in most tissues post-natally, with the exception of sustained expression in the germline in adults (Hammer et al., 2005; Hansen et al., 2004) . IMP2 mRNA, however, remains expressed in adult murine tissues (Bell et al., 2013) . IMP1 is necessary for proper embryogenesis (Hansen et al., 2004) , and IMPs are upregulated in many different types of cancer including lung, liver, breast, and colon, with expression being tightly correlated with poor patient prognosis (Dimitriadis et al., 2007; Ross et al., 2001) .
Molecular mechanisms of how IMP proteins bind and regulate their target RNAs have been studied predominantly in vitro. Molecules of IMP1 protein bind RNA cooperatively and sequentially, dimerizing to form a stable complex with bound RNA via the hnRNP K homology (KH) domains 1-4 . All four KH domains contribute to RNA binding and are important for localization of IMP (Nielsen et al., 2002) . Furthermore, both IMP2 and IMP3 are able to heterodimerize on a target RNA with IMP1 via the four KH domains . Identification of IMP1 RNA targets in vivo revealed IMP1 modulates development and differentiation by regulating various stages of RNA processing. The namesake target of the IMP family, IGF2, is primarily regulated at the level of translation, but IMP1 can either promote or repress translation of IGF2 depending on cellular context (Dai et al., 2013; Nielsen et al., 1999) . IMP1 also controls the localization and translation of neuron-specific Tau mRNA in a differentiation-dependent manner (Atlas et al., 2007) and controls stability of MYC RNA (Bernstein et al., 1992) .
Although these studies in cell lines and model organisms have provided clues into IMP regulation of a small number of RNAs, our understanding of how the IMP-RNA target orchestra is conducted transcriptome-wide in human development is incomplete. In HEK293 cells, Hafner et al. (2010) surveyed the genomewide binding preferences of all three IMPs overexpressed with photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) and Jønson et al. (2007) surveyed the RNAs in IMP1 RNP complexes using RNA immunoprecipitation followed by microarray (RIP-ChIP). However, whether overexpression recapitulates endogenous binding is always a concern with RBPs, and indeed it was recently shown that exogenous expression of IMP1 results in aberrant sedimentation in polysomal gradient centrifugation when compared with endogenous protein (Bell et al., 2013) . Therefore, to study the normal roles of endogenous IMP proteins in hESCs, we integrated two recently developed approaches: enhanced UV crosslinking and immunoprecipitation followed by high-throughput sequencing (eCLIP) to identify the endogenous RNA targets of IMP1, IMP2, and IMP3 in vivo, and RNA Bind-n-seq (RBNS) to uncover the in vitro binding preferences of full-length IMP1 and IMP2 proteins. These approaches revealed highly overlapping binding for IMP1 and IMP2 that was distinct from IMP3, suggesting the IMP family plays both redundant and distinct functions in hPSCs. Further, loss of IMP1 leads to defects in cell survival and adhesion in hPSCs that can be partially explained through its effects on direct targets BCL2 and ITGB5, respectively. Thus, profiling of endogenous IMP1 targets in hPSCs reveals insight into the pathways through which well-characterized IMP1 functions are achieved in stem cells.
RESULTS

Enhanced CLIP Identifies Targets of IMP1, IMP2, and IMP3 Proteins in Human Embryonic Stem Cells
The human IMP family of RNA binding proteins (RBPs) consists of three members (IMP1, IMP2, and IMP3) that contain two RNA recognition motifs (RRMs) and four KH domains each (Figure 1A) . Previous reports have observed significant expression of all three IMP proteins in pluripotent and cancer cell lines, with expression in differentiated tissues mostly limited to IMP2 (Bell et al., 2013) . Analyzing public RNA sequencing (RNA-seq) datasets (Marchetto et al., 2013) , we confirmed that all three members are highly expressed at the mRNA level in PSCs relative to differentiated tissues ( Figure 1B) . At the protein level, we validated that IMP1, IMP2, and IMP3 are all expressed in undifferentiated human ESC lines H9 and HUES6 and an induced pluripotent stem cell (iPSC) line, whereas IMP2 is also expressed in the parental fibroblasts from which the iPSC line was generated ( Figure 1C ). Further, immunohistochemical staining (Figure 1D ) and subcellular fractionation ( Figure 1E ) in H9 hESCs demonstrated dominant cytoplasmic localization of all three IMP proteins. Thus, we selected H9 hESC to identify the RNA targets of IMP proteins in pluripotent stem cells. To uncover molecular pathways in PSCs regulated by IMP proteins, we utilized an enhanced iCLIP (eCLIP) protocol to identify transcriptome-wide RNA targets of the IMP proteins (Konig et al., 2011; Van Nostrand et al., 2016) . Briefly, H9 hESCs were subjected to UV-mediated crosslinking, lysis, and treatment with limiting amount of RNase, followed by immunoprecipitation (IP) of protein-RNA complexes using commercially available antibodies that specifically recognize IMP1, IMP2, or IMP3 (Figures 2A and S1A) . RNA fragments protected from RNase digestion by IMP protein occupancy were subjected to 3 0 RNA linker ligation, reverse-transcription, and 3 0 DNA linker ligation to generate eCLIP libraries for high-throughput Illumina sequencing. eCLIP improves these ligations to >70% efficiency, significantly increasing the number of non-PCR duplicate reads that can be obtained after high-throughput sequencing (Van Nostrand et al., 2016) . Specificity of the antibodies was evaluated by western blotting with recombinant human IMP1, IMP2, and IMP3 proteins ( Figure S1A ). Co-immunoprecipitation experiments in H1 hESCs demonstrate that the IMP1 and IMP2 antibodies do not enrich any of the other family members, while IMP3 appears to slightly co-immunoprecipitate IMP1 ( Figure S1B ).
We generated biological replicate eCLIP libraries for IMP1 and IMP2 and single replicates for IMP3, a negative control (IgG-only IP) and an unrelated RBP (RBFOX2) ( Figures S1C  and S1D ). The improved efficiency of eCLIP enabled us to (A) Schematic of enhanced CLIP protocol. In brief, H9 hESCs were subjected to UV-mediated crosslinking, lysis, and treatment with limiting amount of RNase, followed by immunoprecipitation (IP) of protein-RNA complexes. RNA fragments protected from RNase digestion were subjected to 3 0 RNA linker ligation, Figure S2C ) and IgG (R 2 values of $0.5; example IMP1 replicate shown in Figure S2D ). Figures 2F and S2N) . Furthermore, we observed that rather than interacting with a specific limited set of RNA substrates, there was widespread enrichment in binding to particular regions within genes, as 3 0 UTRs were enriched for IMP1 and IMP2 binding by 2.7-to 4.4-fold (median values) above SMInput IP ( Figures 2B, 2G , and S2E). This was notably higher than coding exons, which were enriched by only 1.2-to 1.7-fold. Analysis of IMP3 binding revealed an opposite trend, as coding exons were 2.9-foldenriched while 3 0 UTRs were only 2.3-fold-enriched ( Figures  2G and S2F ). Consistent with their cytoplasmic localization, depletion of intronic signal globally across all introns was observed for all three IMP family members (depleted 1.9-and 2.3-fold for IMP1, 1.8-and 2.1-fold for IMP2, and 1.7-fold for IMP3, respectively) ( Figures 2B, 2G , and S2E-S2H). These global enrichments for coding exons (depleted in both) or 3 0 UTRs were not observed for IgG or RBFOX2 (1.3-fold-enriched in IgG, depleted in RBFOX2). We conclude that the IMP1 and IMP2 proteins exhibit remarkably similar binding preferences to 3 0 UTRs of mature mRNAs, and IMP3 binding is enriched for coding exons.
Discovery of Reproducible IMP1 and IMP2 Binding Sites by Input Normalization
Due to their similarity in 3 0 UTR preferences, we chose to continue evaluating IMP1 and IMP2. To identify high resolution IMP1 and IMP2 binding sites, standard CLIP-seq cluster discovery was performed using CLIPper (Lovci et al., 2013) . We identified 62,784 and 95,577 clusters for two biological replicates of IMP1 and 57,648 and 66,928 clusters for IMP2 replicates, with cluster sizes 36-40 bases on average (Figures 3A and S3A; Table  S1 ). Next, as SMInput normalization significantly improves signal-to-noise in identifying true binding sites (Van Nostrand et al., 2016) , we compared the read density in IP and SMInput within clusters to compute the enrichment of each cluster above SMInput ( Figure S3B ). As in the regional comparisons, fold enrichment at the cluster level exhibited high correlation across biological replicates (R values 0.54 and 0.51 for IMP1 and IMP2, respectively), whereas low correlation was observed when IMP1 (or IMP2) was compared to IgG or RBFOX2 ( Figures S3C-S3F ). Additionally, ranking clusters by fold enrichment makes them amenable to irreproducible discovery rate (IDR) analysis, a standard metric to evaluate the reproducibility of binding sites across biological replicates (Li et al., 2011) . We observed that IMP1-IMP1 or IMP2-IMP2 comparisons yielded thousands of reproducible clusters at a 0.01 IDR threshold (where 1% of peaks do not reproduce), whereas identical comparisons with IgG or RBFOX2 yielded less than ten reproducible clusters ( Figure 3B ). These orthogonal computational approaches indicate that eCLIP of IMP1 and IMP2 yield highly reproducible binding at both the cluster and read-density-within-cluster levels.
For further analysis, we identified a set of 1,884 and 7,004 high-confidence peaks in IMP1 and 1,572 and 4,494 in IMP2 that meet stringent enrichment criteria (p % 10 À5 and R8-foldenriched versus SMInput) ( Figures 3A and S3A ). In contrast, IgG eCLIP identified only 142 clusters that satisfy these criteria. These stringent binding sites were highly reproducible, as over 66% of stringent clusters identified in the first biological replicate overlapped clusters in the second for both IMP1 and IMP2 (Figures 3A and S3A) . Consistent with our regional analyses, IMP1 and IMP2 binding sites were generally located within the 3 0 UTR and to a lesser extent, within coding exons (Figures 3C, S3I, and S3J). Thus eCLIP identifies thousands of highly confident and reproducible IMP1 and IMP2 binding sites.
High-Resolution IMP1 and IMP2 Binding Is Highly Correlated
As we observed substantial correlation between IMP1 and IMP2 binding at the region level, we next compared IMP1 and IMP2 at the binding site level. Pairwise comparisons indicated 2,495 and 4,301 peaks (at the 0.01 IDR threshold), on par with that observed for biological replicates ( Figure 3B ). We further observed high correlation of input-normalized signal intensity (R = 0.42 and 0.47 for IMP1 Rep1 versus IMP2 Rep2 and IMP1 Rep2 versus IMP2 Rep1 , respectively), indicating that the association of IMP1 and IMP2 is highly similar across thousands of binding sites (Figures S3G and S3H) . To test whether these factors were associating to the same short regions or simply binding nearby each other, we next considered the distribution of read intensity around peak centers. Considering a window of 600-nt centered on the midpoint of IMP1 peaks from an independent biological replicate, we observed that both IMP1 and IMP2 read density are enriched at the peak centers ( Figure 3D ). Thus, despite the IMP1 and IMP2 antibodies showing very little cross-immunoprecipitation ( Figure S1B ), analysis of our eCLIP data at both the region-and cluster-level indicates that IMP1 and IMP2 binding signals are as highly correlated as biological replicates of IMP1 or IMP2.
RNA Bind-N-Seq Identifies CA-Rich Motifs Enriched in Coding and 3 0 UTR Binding Sites To characterize the sequence specificity of IMP proteins, we applied RNA Bind-N-seq (RBNS) (Lambert et al., 2014) to purified full-length human IMP1 and IMP2. After incubation of protein with randomized RNA pools, affinity purification, and highthroughput sequencing, we performed motif analysis to calculate enrichment over input (R) values (Figures 4A, S4A, and S4B) . This identified two CA-rich motifs for each IMP: a primary motif exemplified by AY(A)1YA and secondary motif exemplified by Y(A)2YA ( Figures 4B and 4C) , with many enriched 6-mers (52% for IMP1, 49% for IMP2) containing one of four 4-mers (CACA, UACA, AACA, CAUA), similar to previously identified IMP motifs (Alipanahi et al., 2015; Hafner et al., 2010; Ray et al., 2013) . We observed a high correlation between IMP1 and IMP2 6-mer enrichments (R 2 = 0.788) ( Figure 4D ), whereas IMP1 and RBFOX2 were uncorrelated (R 2 = 0.018) ( Figure 4E ), indicating that the RBNS assay captured IMP-specific binding signatures. Next, we interrogated whether hESC IMP binding sites identified by eCLIP were enriched for the RBNS-identified in vitro motifs. We found that hexamers containing the CACA core sequence were shifted toward higher IMP1 RBNS enrichments, and they also showed greater enrichments among IMP1 eCLIP 3 0 UTR and CDS binding sites than other hexamers (Figures 4F and S4C) . Other RBNS motifs (UACA, AACA, CAUA) showed more variable enrichment, suggesting a distinguishable difference between in vitro and in vivo binding preferences ( Figures  4F-4H ). The enrichment for the CACA motif was more significant when using the subset of stringent CLIP-enriched peaks, consistent with these peaks having improved signal-to-noise (D) Plot indicates the normalized read density for indicated eCLIP experiments (Rep2 for IMP1 and IMP2), centered around the midpoint of significantly enriched IMP1 peaks (described in A) identified from an independent biological replicate (Rep1). Read densities across each peak region were normalized within the 600 nt window, and mean (points) and SEM (error bars) were calculated across all peaks for both eCLIP and paired SMInput datasets as indicated. See also Figure S3 and Table S2 . ( Figures 4G and S4D ). IMP2 showed similar enrichment for CArich sequences in both RBNS and eCLIP binding sites (Figure 4H Figures S5A and S5B ). Total RNA was extracted from three biologically independent transductions of IMP1 shRNA and two transductions of a non-targeting shRNA to generate RNA-seq libraries, which were then sequenced ( Figure S5C ). Of the 17,013 expressed genes analyzed, we identified 257 decreased and 467 increased genes with significantly altered expression (R2-fold and p % 0.05 versus non-targeting control) upon IMP1 depletion ( Figure S5D ). When we compared global IMP1 RNA targets to genes affected by IMP1 depletion, we did not observe any meaningful correlation between genes that were bound and trends in gene expression changes ( Figure S5E ). Nevertheless, when we considered the most CLIP-enriched 3 0 UTRs for IMP1, we observed significant enrichment for genes involved in cell-cell and cell-extracellular matrix (ECM) adhesion ( Figure 5A ). As IMP1 regulation of cell adhesion has been well characterized in cancer cell-lines (Gu et al., 2012; Vikesaa et al., 2006) , we performed a quantitative crystal violet adherence assay following IMP1 depletion to determine whether loss of IMP1 affected adhesion in H9 hESCs. We found that IMP1 KD cells showed significantly decreased adherence compared to control shRNA-treated cells (p < 0.05), even within the first hour after plating, indicating that cell adhesion is also affected by loss of IMP1 in hESCs ( Figures 5B-5D ). We also observed that the actin cytoskeleton and cytoskeletal organization appeared disrupted upon IMP1 depletion ( Figures S5F and S5G) . However, analysis of our RNA-seq data did not indicate altered RNA levels of known IMP1 targets previously shown to modulate cell adhesion, such as CTNNB1 (in breast cancer cells) (Gu et al., 2008) or CD44 (in adenocarcinoma cells) (Vikesaa et al., 2006) . In particular, despite having enriched IMP 3 0 UTR binding (Figure S5H) , we could observe no mRNA or protein change for CTNNB1 in IMP1 KD cells ( Figure S5I ). Similarly, although the F-actin anchoring, cell adhesion protein vinculin (VCL) was one of the most enriched genes in our eCLIP dataset (over 20-foldenriched relative to SMInput), VCL did not appear to be affected at the RNA or protein level upon loss of IMP1 ( Figures S5J and  S5K ). Thus, we observe cell adhesion defects as a consequence of IMP1 depletion in hESCs, but the phenotype cannot be explained simply by regulation through previously characterized IMP1 targets. Given that IMP1 binding alone was insufficient to predict mRNA level effects, we next focused on IMP1 target genes that harbored enriched binding sites in the 3 0 UTR and whose levels were also affected in the IMP1 KD RNA-seq data. Surprisingly, we observed that multiple genes in the integrin family were bound by IMP1 and were downregulated upon depletion of IMP1 (Figures 5E and 5F ). Integrins are known to have significant roles in extracellular signaling and cell adhesion across various systems, with ITGB5 and ITGB1 specifically described to play key roles in human stem cell maintenance and cell adhesion (Braam et al., 2008) . Interestingly, ITGB5 was the most downregulated of all of the integrin genes and contained regions of enriched read density within the 3 0 UTR compared to SMInput or RBFOX2 ( Figure 5G ). We performed RNA immunoprecipitation (RIP) followed by RT-PCR in an independent hESC line (HUES6) and observed IMP1 enrichment on ITGB5, with ACTB mRNA as a positive control (Figure 5H ), validating the interaction between IMP1 and ITGB5 mRNA. Additionally, we confirmed downregulation of ITGB5 and ITGB1 mRNAs in IMP1 KD cells using two independent shRNAs ( Figure 5I ) and further observed significant depletion of ITGB5 protein upon IMP1 loss ( Figure 5J ). Next, we considered potential mechanisms for IMP1 regulation of ITGB5. To test whether IMP1 affects ITGB5 mRNA levels post-transcriptionally at the level of mRNA turnover, we treated hESCs with actinomycin D (ActD) to inhibit the transcription of newly transcribed RNA and collected total RNA after 60 and 120 min. Quantification of mRNA levels by qRT-PCR revealed that ITGB5 was destabilized more quickly in the IMP1 KD cells compared to cells treated with a control shRNA ( Figure 5K ). Interestingly, ITGB1 did not show this destabilization upon IMP1 depletion ( Figure S5L ), confirming specificity of this approach and indicating that IMP1 may regulate various integrins differently. Taken together, these results indicate that the well-characterized role of IMP1 in maintaining proper cell-cell interactions is conserved in hESCs, but that the downstream effectors in hESCs include unanticipated integrin targets like ITGB5, which is regulated at the level of mRNA turnover.
IMP1 Target BCL2 Enhances Survival of IMP1-Depleted hESCs
In addition to cytoskeletal defects, depletion of IMP1 also led to a drastic reduction in hESC colony size ( Figure 6A ). Embryoid bodies derived from IMP1 KD cells were substantially and consistently smaller than those derived from controls ( Figure S6A ). In order to determine whether depletion of IMP1 led to a decrease in proliferation, which could explain a decrease in colony size, we performed fluorescence-activated cell sorting (FACS) analysis using the proliferation antigen KI-67. We observed only a slight, but insignificant, difference between IMP1-depleted and control cells using two independent shRNAs targeting IMP1 (Figure S6B) . To further analyze a potential role for IMP1 in hESC proliferation, cell-cycle analysis was conducted by BrdU and propidium iodide (PI) staining followed by FACS. IMP1 KD cells exhibited a moderate, but significant decrease in the S phase population (p < 0.01), along with an increase in the number of cells in G2 (p < 0.05) ( Figure S6C ). Supporting the hypothesis that a loss of IMP1 leads to an increase in cell death, we detected a statistically significant increase in Annexin V-positive IMP1 KD cells compared to controls by FACS (p < 0.05) ( Figure 6B ). 
(legend continued on next page)
Additionally, we observed a significant increase in levels of cleaved-Caspase 3 upon reduction of IMP1, but not in controltreated hESCs ( Figure 6C ). Together, these results strongly indicate that IMP1 plays an important role in hPSC survival.
To determine the molecular mechanism by which IMP1 impacts hESC survival, we examined anti-apoptotic factors in our IMP1
KD RNA-seq data as candidate targets of IMP1 and found that BCL2 (B cell lymphoma 2) was decreased by 2-fold (Table S4 ). This decrease in BCL2 was confirmed at the mRNA level by qRT-PCR ( Figure 6D) and at the protein level by western blot analysis ( Figures 6C and S6D) . Interestingly, the BCL2 3 0 UTR contains CA-rich sequences ( Figure S6E ) and was >2-fold-enriched over SMInput in both IMP1 eCLIP datasets; however, BCL2 fell below our standard significance cutoffs due to low RNA expression (Table S2 ). Nevertheless, we confirmed IMP1 binding by performing RIP followed by RT-PCR in HUES6 hESCs ( Figure 6E ). To further investigate IMP binding preferences to CA-rich sequences, as previously shown by RBNS, we performed an electrophoretic mobility shift assay (EMSA) with full-length recombinant human IMP1 protein and both wild-type (WT) and mutated versions of the BCL2 3 0 UTR (88 bp segments, see Experimental Procedures). The wild-type ACTB zipcode (IMP binding site) and a truncated ACTB zipcode were used as positive and negative controls, respectively. We were able to detect an interaction between IMP1 and the wildtype BCL2 3 0 UTR in vitro using 200 nM recombinant IMP1 protein ( Figure 6F ). Upon mutation of the CACA motif to GAGA, the binding affinity was dramatically reduced, indicating that IMP1 interacts specifically with the CA-rich motif that constitutes an IMP1 binding site within BCL2 3 0 UTR. Finally, to evaluate whether restoring levels of BCL2 can suppress cell death as a consequence of IMP1 depletion, we utilized a doxycyclineinducible lentiviral system (Ardehali et al., 2011) to ectopically express BCL2 in IMP1 KD hESCs. Using the Caspase-Glo assay we measured apoptosis following a titration of BCL2 overexpression with doxycycline and found that BCL2 is able to rescue the IMP1 KD cell death phenotype ( Figures 6G, S6F , and S6G). Therefore, our data indicate that one pro-survival function of IMP1 in hESCs is to maintain adequate levels of BCL2 mRNA and, consequently, maintain its anti-apoptotic activity.
DISCUSSION
Using systematic, transcriptome-wide mapping with eCLIP, we identified thousands of IMP1, IMP2, and IMP3 binding sites within RNA targets in hESCs. IMP1 and IMP3 are typically viewed as the most related family members, with greater similarity at the protein sequence level (Nielsen et al., 1999) , expression patterns across tissues and development (Bell et al., 2013 ) and co-immunoprecipitation during CLIP ( Figure S1B ), whereas IMP2 has been associated with more distinct roles, such as in metabolism (Dai et al., 2011 (Dai et al., , 2015 Janiszewska et al., 2012) . Thus, hESCs (that express IMP1, IMP2, and IMP3) present a unique opportunity to observe redundant or co-regulation of RNA targets by multiple IMP family members. Surprisingly, we observed substantial overlap between IMP1 and IMP2 binding that was not observed between IMP1 and IMP3, indicating it is not simply an artifact of analyzing cytoplasmic factors with CLIP. Despite the large number of IMP1-bound mRNAs and quite dramatic phenotypes upon knockdown of IMP1 in hESCs, we observed relatively few transcripts strongly bound by IMP1 to be altered when RNA-seq was performed in hESCs depleted of IMP1. In contrast, previous studies in HEK293 cells observed a small but significant shift toward decreased expression (presumably by decreased RNA stability) of IMP targets when all three IMP proteins were simultaneously depleted (Hafner et al., 2010) . These results suggest that IMP family members may share redundant regulatory roles, particularly during development and in cancer when multiple family members are expressed at high levels. The distinct binding to CDS regions observed for IMP3 suggests that further studies may yet reveal additional regulatory roles distinct from IMP1, although the severe phenotypes observed upon individual knockdown by shRNA of IMP1 and IMP2 presents a challenge to detailed characterization of redundancy among IMP family members in hESCs.
At the region-level, we observed significant IMP1 binding to a substantial fraction of all 3 0 UTRs. Although such widespread binding has been described for core RNA processing factors, such as the nonsense-mediated decay regulator UPF1 (Lee et al., 2015) , previous studies of IMP have largely focused on a small number of specific targets. Although the degree of widespread binding is unexpected, it may help to explain why detailed studies of individual IMP targets have not identified one specific mechanism or pathway of regulation; rather, IMP binding has been shown to participate in a broad range of RNA processing regulation steps, including mRNA stability (Leeds et al., 1997) , mRNA localization (Atlas et al., 2007; Ross et al., 1997) , both inhibition of and enhancement of translation (Dai et al., 2011; Nielsen et al., 1999) , and even potentially nuclear export (H€ uttelmaier et al., 2005; Wu et al., 2015) . Thus, considering IMPs as broad regulators may provide insight into how these factors can achieve these various roles. Future work will be needed to better characterize how different IMP targets are directed toward distinct regulatory mechanisms.
Although standard UV 254 crosslinking provides specificity by requiring interacting molecules to have reactive groups within one bond length apart (Wagenmakers et al., 1980) , the frequency See also Figure S5 and Tables S3 and S4. of crosslinking is substantially decreased at non-Uridine bases (Sugimoto et al., 2012) , limiting the ability of IMPs to crosslink at a CA-rich motif. Thus, to complement our eCLIP profiling data, we performed RBNS to characterize the in vitro binding motif for full-length IMP1 and IMP2 proteins (each including all six RNA binding domains). This method revealed that recombinant IMP1 and IMP2 proteins harbor strong preferences for CA-rich motifs with a degenerate CAU within them, correlating well with the MAHWCA motifs identified for IMP2 and IMP3 using an independent in vitro method RNACompete (Ray et al., 2013) as well as the CA motif identified in DeepBind re-analysis of RNACompete data (Alipanahi et al., 2015) . Profiling in vivo by PAR-CLIP identified a similar but slightly altered motif (CAU) (Hafner et al., 2010) , possibly influenced by crosslinking at 4SU nucleotides in PAR-CLIP. These motifs all share strong similarity with motifs described by detailed molecular studies of individual IMP targets (Chao et al., 2010) . The CA-rich motif was significantly enriched in eCLIP peaks, providing further validation that this motif likely represents a major component of IMP1 and IMP2 binding. As IMP binding is often complex, requiring specific spacing of associated motifs to drive dimerization (potentially of multiple IMP family members) , more detailed biochemical studies should provide insight into whether the CA repeat is more critical for binding initiation or (G) Caspase-Glo apoptosis assay. BCL2 protein was induced with increasing amounts of doxycycline after which apoptosis was measured via luminescence using the Caspase-Glo 3/7 assay. A single asterisk indicates significance of p < 0.05, and two asterisks indicate significance of p < 0.01, determined by unpaired t test. Data are shown as mean ± SD. See also Figure S6 and Tables S3 and S4. stabilization of IMP complexes and what role these other motifs play in directing IMP target recognition. Given the relatively small transcriptome change observed upon IMP1 knockdown in hESCs, we were surprised to observe that loss of IMP1 led to dramatic cellular phenotypes, including increased apoptosis and a loss of cell adhesion and cytoskeletal integrity. As IMP roles in maintenance of cell adhesion have been previously described (Gu et al., 2012; Vikesaa et al., 2006) , we asked whether the cell adhesion defect in hESCs could be explained by known or novel targets. We observed that there was a specific enrichment for downregulation of integrin mRNAs, particularly those most strongly bound by IMP1 ( Figure 5 ). Further analysis validated IMP regulation of the stability of ITGB5. These results indicate that in addition to known IMP1 regulatory targets such as CTNNB1 and CD44 that play critical roles in maintenance of proper cell adhesion (Gu et al., 2012; Vikesaa et al., 2006) , the integrin family represents an additional cell adhesion regulatory mechanism for IMP1. Future work to determine whether integrin regulation by IMP1 is specific to hESCs or affects cell adhesion in other systems and the direct mechanisms (including additional co-factors) through which IMP1 binding modulates stability of ITGB5 will provide further insight into the cell-type-specificity of the mechanisms through which IMPs regulate cell adhesion.
Although loss of cell adhesion partially explains the dramatic hESC cell viability defect upon IMP1 knockdown, we noted that apoptotic markers were also increased. Global analyses of either eCLIP-bound or differential transcripts did not show general enrichments for apoptosis or related pathways. However, closer inspection of IMP1 bound and responsive targets identified BCL2, which encodes a critical anti-apoptotic protein, as another IMP1 target that decreases upon IMP1 depletion in hPSCs. Pursuing this further due to the well-characterized roles of BCL2 in mediating apoptotic signals, we found that re-expression of BCL2 in hESCs partially rescued the cell death phenotype resulting from IMP1 depletion in a dose-dependent manner, confirming the contribution of BCL2 to IMP1 knockdown phenotypes in hESCs. The linkage of IMP1 with direct regulation of BCL2 further associates IMP1 with known oncogenic pathways and may provide an interesting avenue for further studies of IMP1 in other cell types, particularly with respect to understanding its roles in modulating tumorigenesis and metastasis. Thus, our results indicate that we are far from an exhaustive list of functional IMP family targets, and further elucidation of the direct and regulated targets of IMP proteins in their various cellular contexts (whether in normal or cancerous cell-types) may provide insights into the distinct and shared roles these proteins play in development and tumorigenesis. In addition to the RBP-IPs a parallel size-matched input (SMInput) library was generated; these samples were not immunoprecipitated with anti-RBP antibodies but were otherwise treated identically (to aid in the removal of false positives). One SMInput was used for each biological replicate grouping of all IMP proteins due to their similarity in molecular weight, with a separate SMInput generated for RBFOX2. Stringent washes were performed as described in iCLIP, during which RNA was dephosphorylated with FastAP (Fermentas) and T4 PNK (NEB). Subsequently, a 3 0 RNA adaptor was ligated onto the RNA with T4 RNA ligase (NEB). Protein-RNA complexes were run on an SDS-PAGE gel, transferred to nitrocellulose membranes, and RNA was isolated off the membrane identically to standard iCLIP. After precipitation, RNA was reverse transcribed with AffinityScript (Agilent), free primer was removed (ExoSap-IT, Affymetrix), and a 3 0 DNA adaptor was ligated onto the cDNA product with T4 RNA ligase (NEB). Libraries were then amplified with Q5 PCR mix (NEB). See Van Nostrand et al. (2016) for further details regarding standardized eCLIP experimental workflows.
eCLIP-Seq Read Processing and Cluster Analysis
Briefly, reads were adaptor trimmed (cutadapt), mapped against repetitive elements (with repeat-mapping reads discarded), and then mapped to the human genome with STAR. PCR duplicate reads were removed, and the second (paired-end) read was used to perform peak-calling with CLIPper (Lovci et al., 2013) . Region-level analysis was performed by counting reads overlapping regions annotated in Gencode (v19). hPSC Cell Culture All hPSC lines (including H9, H1, HUES6, and iPSC) lines were grown on Matrigel (BD Biosciences) using mTeSR1 medium (Stem Cell Technologies). Cells were routinely passaged using Dispase (2 mg/ml) and scraping the colonies with a glass pipet. For assays requiring single-cell dissociation, Accutase (Innovative Cell Technologies) was used followed by culture medium supplemented with 10 mM Rock Inhibitor Y-26732 (Calbiochem) for 24 hr. See the Supplemental Experimental Procedures for further details.
Lentiviral Vectors, Production, and hESC Infection
If not otherwise indicated, experiments were performed using pLKO lentivirus constructs TRCN0000075149 for IMP1, TRCN0000255463 for IMP2, TRCN0000074675 for IMP3, and non-target control Sigma #SHC002 (that targets turboGFP). Two additional shRNAs were tested for IMP1, TRCN0000218079 that targeted the CDS (shRNA 2) and TRCN0000230114 that targets the IMP1 3 0 UTR (shRNA 3). Unless otherwise noted, shRNA 3 (TRCN0000230114) was used as the second shRNA for phenotypic experiments. See the Supplemental Experimental Procedures for additional details.
Adhesion Assay
After virus transduction and puromycin selection, hES cells were plated out at 50,000 cells per well in a 96-well plate coated with Matrigel, incubated for 1 hr at 37 C with 5% CO 2 , vortexed at 2,000 rpm for 15 s, washed three times with 0.1% BSA in DMEM/F12, and fixed with 4% paraformaldehyde for 10 min at room temperature. Following fixation, cells were washed with 0.1% BSA in DMEM/F12 and stained with crystal violet (5 mg/ml in 2% EtOH) for 10 min. Cells were then rinsed with H 2 O and left to completely dry for 15 min. SDS (2%) was added for 20 min followed by absorbance reading on a plate reader. Data are represented as mean ± SD, with statistical significance calculated by unpaired t test.
BCL2 Rescue Apoptosis Assay H9 hESCs expressing control and IMP1 shRNAs were split into four biological replicates each and transduced with dox-inducible BCL2 viruses. After 24 hr, three replicates were each re-plated into four wells of a 96-well plate at a density of 20,000 cells per well. A titration of doxycycline was added for 24 hr after which apoptosis was measured by the Caspase-Glo 3/7 assay (Promega). The Caspase-Glo 3/7 assay was performed according to the 
RNA Extraction and qRT-PCR Analysis
Total RNA was isolated using Trizol Reagent (Invitrogen) according to the manufacturer's recommendations, DNase treated with Turbo DNA-free kit (Ambion), and cDNA synthesized from 2 mg total RNA using the SuperScript III Reverse Transcriptase kit for qRT-PCR (Invitrogen). Both random hexamers and oligo(dT) primers were used for reverse transcription. Real-time PCR was performed using the SYBR-Green FAST qPCR Master mix (Applied Biosystems) on a CFX384 Touch Real-Time PCR Detection System (Bio-Rad).
Values of gene expression were normalized using an average of 18s, GAPDH, and HMBS with the exception of the Actionmycin D experiments (see Figure 5K and Experimental Procedures for details) and are shown as fold change relative to the value of the control shRNA-treated sample. All experiments were performed in technical and biological triplicates. Bars indicate mean ± SEM as measured by the DDCt method. Significance was determined by unpaired t test between the control shRNA sample and IMP1 shRNA sample. See the Supplemental Experimental Procedures for primer sequences used.
Actinomycin D RNA Stability Assay H9 hESCs were treated with 10 mg/ml actinomycin D (Sigma) and RNA was isolated using Trizol at time 0 (no treatment), 60 min, and 120 min after treatment. RNA decay was measured with qRT-PCR normalized to the amount of RNA at time 0 (see RNA Extraction and qRT-PCR Analysis). Values of gene expression were normalized using PPIA and RPLP0, genes determined not to change over the given time period following addition of actinomycin D.
RNA Immunoprecipitation Assay in hESCs RNA immunoprecipitation (RIP) was performed with an input of $20 3 10 6 uncrosslinked HUES6 hES cells lysed with CLIP lysis buffer (Wilbert et al., 2012) . A total of 5 mg of each antibody, Rabbit IgG (Santa Cruz, #SC-2027) and IMP1 (MBL, #RN007P), were coupled to Protein G Dynabeads (Invitrogen) and incubated with pre-cleared cell lysate overnight on rotation at 4 C. Immunoprecipitated RNA was isolated from beads using 1 ml Trizol according to the manufacturer's instructions and reverse-transcribed using the SuperScript III Reverse Transcriptase kit. Endpoint RT-PCR was performed using Crimson Taq DNA Polymerase (NEB).
Electrophoretic Mobility Shift Assay IMP1 electrophoretic mobility shift assay (EMSA) was performed based on the conditions used in Farina et al. (2003) . Binding reactions contained the following: 10 mM Tris [pH 7.5], 50 mM NaCl, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 4% glycerol, 100 ng Escherichia coli tRNA (Roche), 10,000 cpm of the 32 P-labeled target RNA, and increasing amounts of recombinant human IMP1 protein (Origene #TP316226) to a final volume of 20 ml. Reactions were incubated for 30 min at room temperature followed by 15 min on ice.
Reactions were loaded on 5% nondenaturing polyacrylamide TGE gels containing 5% glycerol and run at 150 V for 2 hr. Following electrophoresis, gels were dried and exposed to phosphoimager film. See the Supplemental Experimental Procedures for further details.
RNA Bind-N-Seq RNA Bind-N-seq (RBNS) was performed on full-length GST-SBP-tagged IMP1 and IMP2 as previously described (Lambert et al., 2014) . The motif frequency in the RBP-selected pool divided by the frequency in the input RNA library was calculated for all k-mers (k = 4, 5, 6) and defined as the motif enrichment (R) value. Mean and SD of R values were calculated across all k-mers for each k (4-mers, 5-mers, and 6-mers), with significance thresholds set at Z score R 2. Enrichments from the protein concentration with the greatest enrichment were used for comparison with CLIP peaks, compared against same-sized regions randomly selected from the same genomic region (e.g., 3 0 UTRs or CDS). See the Supplemental Experimental Procedures for additional details.
ACCESSION NUMBERS
The accession number for the IMP eCLIP and knockdown RNA-seq data reported in this paper is GEO: GSE78509. The accession numbers for the Bind-N-Seq datasets reported in this paper are ENCODE DCC (https://www. encodeproject.org): ENCSR928XOW (IMP1) and ENCSR588GYZ (IMP2). 
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